Natural killer (NK) cells play a major role in the immune response against malignant and virus-infected cells through both direct cytotoxicity and immunoregulatory secretion of cytokines affecting other immune cells. NK cells have also been shown to be involved in allergic airway responses in mice 1, 2 and have been implicated to play a role in inflammatory diseases, such as chronic obstructive pulmonary disease (COPD). 3, 4 However, most of our knowledge about NK cells in human subjects comes from analyses of peripheral blood, whereas much less is known about NK cells in peripheral tissues, including the human lung. 5 The lung is regularly exposed to pathogens and environmental toxins and is a common site for tumor formation, particularly in smokers. As such, NK cells in the lung represent a first line of defense against invading pathogens and might play an important role in protection against or modulation of acute and chronic respiratory diseases, as well as cancer. Thus a deeper basic understanding of the composition and function of NK cells in the human lung would be useful for deciphering their role in multiple human pathologic conditions. NK cells can be divided into phenotypically and functionally discrete subsets. The 2 major populations in peripheral blood consist of immature CD56 bright CD16 2 NK cells and more differentiated CD56 dim CD16
1 NK cells. 6 CD56 bright CD16 2 NK cells uniformly express the inhibitory receptor CD94/natural killer group (NKG) 2A but lack expression of killer cell immunoglobulin-like receptors (KIRs) and the differentiation marker CD57. These cells have a low expression of perforin and poor cytolytic function but respond well to cytokines. 6 In contrast, CD56 dim CD16 1 NK cells express high levels of perforin and can readily kill target cells through natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) but respond less well to cytokines. The CD56 dim CD16
1 NK cells can be further divided into more or less differentiated subsets, as defined by the expression of, for example, CD57, CD62 ligand, and NKG2A. 7 NK cell recognition of target cells is determined by a balance between inhibitory and activating receptors expressed on the NK cell surface, where the majority of the inhibitory receptors, such as KIRs and NKG2A, bind to HLA class I. 10 NK cells are functionally educated through expression of NKG2A or inhibitory KIRs that bind to self-HLA class I, and educated NK cells respond well to target cells lacking HLA class I expression, whereas noneducated NK cells are hypofunctional. Through this education, NK cell self-tolerance is maintained while allowing NK cells to respond to target cells lacking HLA class I expression, such as tumors and virus-infected cells. [11] [12] [13] Previous studies have indicated that NK cells make up about 10% of the lymphocytes in the human lung 14 and that the majority of NK cells in peritumoral lung tissue are of a CD56 dim NK cell phenotype. 15 An early study documented a reduction of NK cell cytotoxic activity in mononuclear cells isolated from the lung compared with that in peripheral blood and implied that the cause was mediated through suppressive effects induced by alveolar macrophages. 16 However, that study did not investigate the function of NK cells at the single-cell level and therefore did not control for other variables, such as differences in NK cell frequency and phenotype between the lung and blood. In addition to cellular interactions, NK cells are strongly influenced by cytokines in the surrounding environment. In this context it is worth noting that the spontaneous production of IL-15, a potent activator of NK cells, by bronchial epithelial cells is enhanced by IFN-g stimulation. 17 On the other hand, lung epithelial cells and alveolar macrophages produce TGF-b, 18 which suppresses NK cell function. 19 As such, it is likely that surrounding cells could provide both stimulatory and suppressive signals to NK cells in the lung, depending on conditions such as infection or inflammation.
Although CD56 dim CD16 1 NK cells are the dominant population in peripheral blood, CD56 bright CD16 2 NK cells make up a large part of the NK cells found in several human peripheral tissues, such as the skin, liver, and secondary lymphoid tissues. [20] [21] [22] Furthermore, a large proportion of CD56 bright CD16
2 NK cells in the liver and skin express CD69. 22, 23 CD69 is expressed on a wide range of tissue-resident lymphocytes, including T cells and NK cells, 23, 24 and promotes retention of lymphocytes in the tissue through its interaction with sphingosine-1-phosphate receptor 1. [25] [26] [27] Consequently, CD69 has been used to identify tissue-resident lymphocytes in various peripheral tissues. 24 However, to what extent the human lung is populated predominantly by circulating CD69 2 or tissue-resident CD69 
CD56
dim CD16 1 NK cells were the dominant NK cell population in the human lung. Surprisingly, only a smaller part of the NK cell population in the lung expressed CD69. These results indicate that the human lung is populated mainly by NK cells circulating between the lung and blood rather than by a stable pool of CD69-expressing tissue-resident cells.
METHODS

Patients and lung samples
Lung samples from a total of 132 patients (Table I ) undergoing lobectomy were prospectively collected for this study. None of the patients received preoperative chemotherapy, radiotherapy, or both. Patients with recorded strong immunosuppressive medication, hematologic malignancy, or both were excluded from the study. For some analyses, the patients were grouped according to cigarette smoking status: nonsmokers, current smokers, and ex-smokers (cigarette smoking cessation >1 year before surgery). In addition, peripheral blood was collected from 9 age-matched healthy control subjects (mean age, 59.2 years; range, 50-69 years). The regional review board in Stockholm approved the study, and all donors provided informed written consent before sample collection.
Processing of lung tissue specimens and peripheral blood
For collection of human lung tissue, a small part of macroscopically normal human lung tissue, taken as distal as possible from the tumor site of the resected lung lobe, was cut out. The tissue was transferred into ice-cold Krebs-Henseleit buffer and stored on ice for less than 18 hours until further processing. The tissue was then cut into smaller pieces, embedded in OCT Cryomount (HistoLab, Gothenburg, Sweden), and frozen at 2808C for subsequent microscopic analysis or extensively washed with PBS and incubated in RPMI with DNase (0.2 mg/mL; Roche, Mannheim, Germany) and collagenase II (0.25 mg/mL; Sigma-Aldrich, St Louis, Mo) for 30 to 40 minutes at 378C. After digestion, RPMI supplemented with 10% FCS, L-glutamine, penicillin, and streptomycin (R10 medium) was added, and the cell suspension was passed through a 40-mm cell strainer and washed twice in R10 medium. Finally, mononuclear cells from lung cell suspensions and matched peripheral blood were isolated by means of density gradient centrifugation (Lymphoprep; Axis-Shield, Oslo, Norway).
DNA isolation and KIR/HLA ligand genotyping
Genomic DNA was isolated from 100 mL of whole blood by using a DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany). Genotyping was performed by applying PCR-SSP technology with a KIR typing kit, as well as a KIR HLA ligand kit (both from Olerup SSP, Stockholm, Sweden), according to the manufacturer's instructions.
Degranulation assay
Fresh lung cells and matched PBMCs were resuspended in R10 medium and rested for 15 to 18 hours at 378C. For assays in which NK cells were primed with IFN-a, cryopreserved lung cells and PBMCs were thawed and incubated with 10 4 U/mL IFN-a (PBL Assay Science) for 15 hours before the degranulation assay. Subsequently, the cells were cocultured with R10 medium alone, K562 cells, or 721.221 cells and 1 mg/mL anti-CD20 mAb (Rituximab, Roche) for 2 hours in the presence of fluorescein isothiocyanate (FITC)-conjugated antiCD107a (clone H4A3; BD Biosciences, San Jose, Calif).
Flow cytometry
Antibodies and clones specific for the following proteins were used: CD3 (UCHT1, phycoerythrin [PE]-Cy5; Beckman Coulter, Fullerton, Calif), CD14 (M4P9, Horizon V500; BD Biosciences), CD16 (3G8, Brilliant Violet 711 or Brilliant Violet 785; BioLegend, San Diego, Calif), CD19 (HIB19, Horizon V500; BD Biosciences), CD45 (HI30, Alexa Fluor 700; BioLegend), CD56 (N901, ECD, Beckman Coulter, or HCD56, Brilliant Violet 711), CD57 (TB01, purified; Affymetrix, Santa Clara, Calif/eBioscience, San Diego, Calif), KIR2DL1 (143211, biotin; R&D Systems, Minneapolis, Minn), KIR2DL3 (180701, FITC; R&D Systems), KIR3DL1 (DX9, Alexa Fluor 700; BioLegend), NKG2A (Z199, APC-A780; Beckman Coulter), CD107a (H4A3, PE; BD Biosciences), KIR2DL2/DL3 (GL183, PE-Cy5.5; Beckman Coulter), KIR2DL1/S1 (EB6, PE-Cy7; Beckman Coulter), CD69 (TP1.55.3, ECD; Beckman Coulter), NKG2D (1D11, PE-Cy7; BioLegend), perforin (dG9, FITC; BD Biosciences), and Ki67 (B56, Alexa Fluor 700; BD Biosciences). The cells were stained with mAbs specific for cell-surface antigens, washed twice, and subsequently stained with streptavidin Qdot 605 or Qdot 585 (Invitrogen, Carlsbad, Calif), anti-mouse IgM (II/41, eFluor 650NC; Affymetrix/eBioscience), and Live/Dead Aqua. After surface staining, PBMCs were fixed and permeabilized with a FoxP3/Transcription Factor staining kit (eBioscience) and stained with anti-TNF (mAb 11, Brilliant Violet 421; BioLegend). Samples were analyzed on a BD LSR Fortessa equipped with 4 lasers (BD Biosciences), and data were analyzed with FlowJo version 9.5.2 (Tree Star, Ashland, Ore).
Confocal microscopy
Immunofluorescence was performed on frozen lung tissue sections, as described previously. 28 In brief, the sections were fixed in 2% formaldehyde, washed in PBS and blocked with Image-iT FX Signal Enhancer (Life Technologies, Grand Island, NY), Background Buster (Innovex Biosciences, Richmond, Calif) and 10% FCS (Sigma-Aldrich) in PBS with 0.1% saponin for 30 minutes each before incubation at 48C overnight with a mix of primary antibodies: mouse anti-eomesodermin (Eomes; clone WD1928, (Fig 1, A) . A detailed gating strategy is shown in Fig E1 in 1 ). *P < .05, **P < .01, ***P < .001, and ****P < .0001.
The frequency of lung NK cells was, on average, 15% of live CD14
2
CD19
2 CD45 1 cells, a frequency higher than in matched peripheral blood (Fig 1, B) . Notably, however, one third of the patients had lower frequencies of NK cells in the lung compared with peripheral blood, and the frequency of lung NK cells varied widely between subjects (range, 1% to 60% ; Fig 1,  B) . The majority of lung NK cells had a CD56 dim CD16 1 phenotype, although the frequency of this subset was significantly lower among NK cells in the lung compared with those from the blood (Fig 1, C) . Notably, both smokers and ex-smokers had significantly reduced frequencies of NK cells in the lung compared with nonsmokers, whereas the differences between these groups were less pronounced in peripheral blood (Fig 1, D) . The decrease in frequency of NK cells in smokers and ex-smokers was mirrored by an increased frequency of T cells in the lung (see Fig E2 in 
CD3
2 NK cells were detected in the parenchyma of the lung and were not found outside the parenchyma, such as in blood vessels or bronchi (Fig 1, E) .
Lung CD56 dim NK cells are hypofunctional to target cell stimulation
To test the functionality of lung NK cells, we next analyzed degranulation and TNF production after stimulation with target cells. Lung CD56 dim NK cells were markedly hyporesponsive to stimulation with K562 cells, a prototypic tumor target cell line lacking HLA class I expression, compared with CD56 dim NK cells in matched peripheral blood (Fig 2, A and B) . Lung CD56 dim NK cells also responded less well to stimulation with antibodycoated target cells compared with NK cells in peripheral blood (Fig 2, C) , indicating that the former were impaired both in natural cytotoxicity and ADCC. Decreased functional capacity of CD56 dim NK cells was also observed after stimulation of sorted CD56 dim NK lung cells (see Fig E3 in this article's Online Repository at www.jacionline.org). Notably, NK cells in both lung tissue and peripheral blood from current smokers responded less well than NK cells from ex-smokers (Fig 2, D) . Priming of lung NK cells with IFN-a slightly increased their functional capacity, although to a much lower degree than NK cells from peripheral blood (Fig 2, E) .
To analyze the functional capacity of CD56 bright NK cells in the lung, we stimulated NK cells with phorbol 12-myristate 13-acetate (PMA) and ionomycin and analyzed cytokine production in CD56 bright NK cells (Fig 2, F and G) . Both in peripheral blood and lung tissue, CD56 bright NK cells produced TNF and GM-CSF and upregulated CD107a cell-surface expression (Fig 2, F and G) . However, peripheral blood NK cells exceeded lung NK cells in the expression of CD107a and GM-CSF, whereas TNF production by CD56 bright NK cells was similar in both compartments (Fig 2, F and G) .
Taken together, our results indicate that the human lung contains a high frequency of CD56 dim NK cells, which are largely hyporesponsive to target cells, with a significant decrease in NK cell function in current smokers. Lung CD56 bright NK cells are functional but suppressed in their response compared with their counterparts from peripheral blood.
Human lung NK cells are predominantly terminally differentiated and express educating KIRs
We continued by investigating the differentiation status of NK cells in the lung and peripheral blood. To this end, we analyzed the expression of CD57 and NKG2A on CD56 dim CD16
1 NK cells in the lung and peripheral blood (Fig 3, A) . The frequency of immature CD57
2
NKG2A
1 NK cells was lower in lung samples compared with that in peripheral blood in favor of an accumulation of highly differentiated CD57
1
NKG2A
2 NK cells (Fig 3, B) . NK cell differentiation is also accompanied by acquisition of KIRs. 7 To investigate KIR expression on NK cells in the lung in more detail, we analyzed expression of KIR2DL1, KIR2DL2/S2, KIR2DL3, and KIR3DL1 in parallel with expression of CD57 and NKG2A (Fig 3, C) . A higher frequency of NK cells in the lung expressed KIRs compared with NK cells in matched peripheral blood (Fig 3, D) in addition to a higher frequency of self-KIR-expressing educated NK cells (Fig 3, E) . Taken together, the results show that highly differentiated and KIR-expressing NK cells are enriched in the human lung.
Analysis of CD69 expression on lung NK cells suggests that the dominant NK cell population in human lung is made up of circulating
Expression of CD69 identifies tissue-resident lymphocytes, rather than solely being a marker of recent activation. [24] [25] [26] [27] To investigate to what extent human lung NK cells were primarily resident or rather represented circulating NK cells transiently entering the lung, we analyzed the expression of CD69 on NK cells isolated from lung tissue and matched peripheral blood. As a reference, we also investigated the expression of CD69 on T cells and CD127
1 ILCs in the same samples. A much lower frequency of NK cells in the lung expressed CD69 compared with both T cells and CD127
1 ILCs (Fig 4, A and B) , although NK cells in the lung did express CD69 more frequently than NK cells in peripheral blood (Fig 4, B) . No significant differences in CD69 expression were detected on NK cells between nonsmokers, ex-smokers, and current smokers (data not shown).
CD69 expression by lung NK cells was largely confined to CD56 bright CD16
2 NK cells and a small subset of CD56 dim CD16 1 NK cells (Fig 4, C) . To determine whether the CD69 2 NK cells (Fig 4, D) , whereas there was no significant difference between these subsets in matched peripheral blood (see Fig E4 in 
CD56
dim CD16 1 NK cells in peripheral blood (Fig 4, E) . Furthermore, expression of Ki67, a marker of proliferation, did not differ between CD69
1 and (Fig 2, B) or 721.221 cells and anti-CD20 mAb (rituximab ; Fig 2, C) . Background degranulation by unstimulated CD56 dim NK cells is subtracted. D, Degranulation by NK cells from current smokers (1) and ex-smokers (ex) in peripheral blood (left panel) and lung tissue (right panel). Background degranulation by unstimulated NK cells is subtracted. E, Degranulation (left panel) and TNF production (right panel) by cryopreserved NK cells after stimulation with K562 cells, with or without overnight priming with IFN-a. Background degranulation and TNF production by unstimulated NK cells are subtracted. F and G, Overlay of representative histograms (Fig 2, F) and summary of data showing degranulation, TNF, and GM-CSF production (Fig 2, G) in CD56 bright NK cells with or without phorbol 12-myristate 13-acetate/ionomycin stimulation. *P < .05 and **P < .01.
CD69
2 CD56 dim CD16 1 lung NK cells but was lower overall compared with that in CD56 dim CD16
1 NK cells in peripheral blood (Fig 4, F) 
CD56
dim CD16 1 NK cells in the lung and peripheral blood (Fig 4, G) . Thus these data indicate that NK cells in the lung are predominantly circulating rather than tissue resident, which is in contrast to T cells and CD127
1 ILCs.
DISCUSSION
Although our knowledge about NK cells in peripheral blood has advanced tremendously in the last decades, much less is known about NK cells in human tissues, including the lung. More detailed knowledge about the basic biology of human lung NK cells is required to understand their potential role in response to pathological conditions, such as asthma, COPD, infections, or cancer. Our results show that highly differentiated KIRexpressing CD69 , and KIR3DL1 expression and KIR-HLA ligand genotype. *P < .05, **P < .01, ***P < .001, and ****P < .0001. ). However, the underlying mechanisms governing the skewing of the lymphocyte populations remain largely unknown but could involve changes in the homing capacity of NK cells, increased apoptosis of NK cells, increased expansion of tissue-resident T cells, and/or increased recruitment of T cells.
The fact that CD56 dim CD16 1 lung NK cells were more differentiated and expressed KIRs more frequently than NK cells in the blood indicated a preferential accumulation of highly differentiated NK cells in the lung. In this respect it is interesting to note that the lung contains the highest frequency of differentiated and KIR-expressing NK cells of all tissues, even during human fetal development, 32 and a higher frequency of differentiated NK cells was observed in the mouse lung. 33 Together, these results indicate that the accumulation of differentiated NK cells in the lung is conserved throughout human NK cell ontogeny, as well as between human subjects and mice. However, the factors that drive the accumulation of differentiated NK cells in the lung remain to be investigated but could involve preferential recruitment of differentiated NK cells to the lung or in situ differentiation of NK cells infiltrating the lung. Macrophages and epithelial cells in human adult lung tissue produce TGF-b, which has been shown to induce KIR expression on NK cells in vitro. 34 Thus the cytokine milieu in the lung might also, at least in part, contribute to shaping the phenotype of lung NK cells.
Despite data indicate that the hyporesponsiveness of lung NK cells is not explained by an immature state, lack of educating self-KIRs, or lack of effector molecules. In a previous study both alveolar macrophages and soluble factors in alveolar lavage fluid efficiently suppressed NK cell cytotoxicity in vitro. 16 Together with our data, this indicates that the local environment of the lung, rather than NK cell intrinsic factors, determines their responsiveness. Viral infections that induce high levels of type I interferons could possibly break the quiescent state of lung NK cells. 35 However, priming of lung NK cells with IFN-a in vitro increased their responsiveness only slightly compared to NK cells from peripheral blood (Fig 2, E) . This indicated that IFN-a produced during a viral infection is not sufficient, at least not alone, to rapidly restore full function of NK cells in the lung.
It is increasingly clear that lymphocytes isolated from tissues, including T cells, CD127
1 ILCs, and NK cells, can be divided into tissue-resident and circulating subsets with distinct phenotypic and functional properties. [36] [37] [38] The expression of CD69 on lymphocytes in vivo is linked to tissue retention, rather than solely reflecting recent activation [25] [26] [27] and, as such, is increasingly used as a marker of tissue-resident lymphocytes. Here we show that the vast majority of NK cells in human lungs lacked CD69 expression, whereas the majority of T cells and nearly all CD127 1 ILCs were tissue resident. In contrast, a large part of the NK cells in the salivary glands and, to some extent, the small intestine, remained host derived, 36 indicating that the paucity of tissue-resident NK cells is specific to the lung both in human subjects and mice.
Although the majority of CD56 dim CD16 1 NK cells in the lung lacked expression of CD69, the frequency of CD56 dim CD16
1 NK cells expressing CD69 was higher in the lung than in donormatched peripheral blood. Furthermore, CD69 
